The Amazing Son in Law The Charismatic Charlie Wade

Chapter 3775

The White House wanted the patent for the JX Renewing Pill, which, in Smith's opinion, was both unexpected and justified.

Once the health department reported such information to the White House, they naturally could not let go of this good opportunity.

However, whether they can get the patent in hand, that is not for them to decide.

This kind of medicine, like a super money printing machine, as long as it is in the hands of visionary people, it is impossible to sell the patent.

But Smith also did not throw cold water on the other side, but quickly agreed, saying, "After I meet the other party's head, I will try to promote this matter."

"However, such a big thing, I'm afraid I can't handle it alone, the White House should send a few negotiators over?"

The health minister immediately denied: "This kind of thing is not good for the White House to come out directly,"

"It will make people think that the White House is intending to control the medical field, once the world's governments have begun to intervene, this matter is not good to promote."

this time, first privately explore the other side of the wind, if the other side is interested in making a bid, just fix the money, I

thinking: "The White House operating this kind of thing, indeed very good, they

off to J&J such top big companies to eat it alone, once J&J got

party continued to exhort him: "Smith, you must do everything possible to promote this matter to land, once

out at least a few percentage points of sales a year to play the relationship, including you and me, this is a big

help but get a

go to market, a year of 100 billion dollars in sales easily, if you take out a few percent, at least a few billion

even if they are just a corner,

not help but get excited and said:

party satisfied with a response, and said: "Smith, from the White House side there are instructions, if the patent for this drug can not be attained, you must crack the formula, but before you got the

other's formulas, which must be devastating to the credibility of our entire pharmaceutical patent system, is it not

you afraid of." The other party did not care to say: "This kind of thing we

to our holding company in India to produce

the other